Estrogen Replacement Therapy

"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.

Descriptor ID	D015914
MeSH Number(s)	E02.319.452.150
Concept/Terms	Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogen Replacement Therapies Replacement Therapies, Estrogen Therapies, Estrogen Replacement Therapy, Estrogen Replacement Replacement Therapy, Estrogen Estrogen Replacement Estrogen Replacement Estrogen Replacements Replacements, Estrogen Replacement, Estrogen Postmenopausal Hormone Replacement Therapy Postmenopausal Hormone Replacement Therapy Hormone Replacement Therapy, Post-Menopausal Hormone Replacement Therapy, Post Menopausal Estrogen Progestin Replacement Therapy Estrogen Progestin Replacement Therapy Estrogen Progestin Combination Therapy

Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Hormone Replacement Therapy [E02.319.452]
Estrogen Replacement Therapy [E02.319.452.150]

Below are MeSH descriptors whose meaning is related to "Estrogen Replacement Therapy".

Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.

Bar chart showing 30 publications over 17 distinct years, with a maximum of 3 publications in 2001 and 2002 and 2003 and 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1998	1	0	1
1999	0	1	1
2000	0	2	2
2001	3	0	3
2002	2	1	3
2003	1	2	3
2006	2	1	3
2007	0	1	1
2008	2	0	2
2009	0	2	2
2010	1	0	1
2011	0	1	1
2015	1	0	1
2016	1	0	1
2018	1	0	1
2019	2	0	2

Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.

Klein KO, Phillips SA. Review of Hormone Replacement Therapy in Girls and Adolescents with Hypogonadism. J Pediatr Adolesc Gynecol. 2019 Oct; 32(5):460-468.

View in: PubMed
Backeljauw P, Klein K. Sex hormone replacement therapy for individuals with Turner syndrome. Am J Med Genet C Semin Med Genet. 2019 03; 181(1):13-17.

View in: PubMed
Klein KO, Rosenfield RL, Santen RJ, Gawlik AM, Backeljauw PF, Gravholt CH, Sas TCJ, Mauras N. Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. J Clin Endocrinol Metab. 2018 05 01; 103(5):1790-1803.

View in: PubMed
Pinkerton JV, Pickar JH, Ryan KA, Yu CR, Mirkin S, Komm BS. Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials. Menopause. 2016 06; 23(6):611-20.

View in: PubMed
Stevenson JC, Chines A, Pan K, Ryan KA, Mirkin S. A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials. J Clin Endocrinol Metab. 2015 Jun; 100(6):2329-38.

View in: PubMed
Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, Mauras N. Pharmacokinetics and pharmacodynamics of oral and transdermal 17? estradiol in girls with Turner syndrome. J Clin Endocrinol Metab. 2011 Nov; 96(11):3502-10.

View in: PubMed
Forman EJ, Guyton JR, Filip SJ, Price TM. Implanted estrogen pellets associated with hypertriglyceridemia, biliary dyskinesia and focal nodular hyperplasia of the liver: a case report. J Reprod Med. 2010 Jan-Feb; 55(1-2):87-90.

View in: PubMed
Espeland MA, Tindle HA, Bushnell CA, Jaramillo SA, Kuller LH, Margolis KL, Mysiw WJ, Maldjian JA, Melhem ER, Resnick SM. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci. 2009 Dec; 64(12):1243-50.

View in: PubMed
Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ, Anderson BO, Arun BK, Bartelink H, Bernard P, Bonanni B, Cady B, Clough KB, Feig SA, Heywang-K?brunner SH, Howell A, Isaacs C, Kopans DB, Mansel RE, Masood S, Palazzo JP, Pressman PI, Solin LJ, Untch M. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J. 2009 Jan-Feb; 15(1):4-16.

View in: PubMed
Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Menopause. 2008 Nov-Dec; 15(6):1060-4.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement